Navigation Links
Peripheral Vascular Device Market in the APAC Region 2010-2014
Date:10/12/2011

NEW YORK, Oct. 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Peripheral Vascular Device Market in the APAC Region 2010-2014

http://www.reportlinker.com/p0655254/Peripheral-Vascular-Device-Market-in-the-APAC-Region-2010-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

TechNavio's analysts forecast the Peripheral Vascular Devices market in the APAC region to grow at a CAGR of 11 percent for the period 2010–2014. One of the key factors contributing to this market growth is the increase in abdominal aortic aneurysms and peripheral arterial disease. The Peripheral Vascular Devices market in the APAC region has also been witnessing an increase in the growth of vascular stents in Japan. However, infections from peripheral vascular implantation and surgeries could pose a challenge to the growth of this market.

Key vendors dominating this market include Medtronic Inc., Abbott Laboratories, Boston Scientific Corp., Cordis Corp., and Cardiac Science Corp.

TechNavio's Peripheral Vascular Device Market in the APAC Region 2010–2014 report has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on the APAC region and covers the products used for PVD treatments and surgeries. This report also includes a discussion on key vendors operating in this market.

Key questions answered in this report:

What will the market size be in 2014 and at what rate will it grow?

What key trends is this
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
2. Global Peripheral Vascular Devices Market 2010-2014
3. BridgePoint Medical Announces US IDE Approval and First Patient Enrollment of Peripheral Chronic Total Occlusion Study
4. Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion
5. Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
6. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
7. New Study Shows Tapentadol Extended Release (ER) May Significantly Reduce Average Pain Intensity for Diabetic Patients Suffering From Painful Peripheral Neuropathy
8. Reportlinker Adds Overview of the Western European Peripheral Interventional Devices Market
9. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
10. First Hotspur Peripheral Angioplasty Case Completed
11. Vermillion Announces Issuance of Patent for Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 According ... Adhesives Market by Product (Natural & Synthetic, Fibrin, Collagen, ... Cosmetic Surgery) - Global Forecast to 2020", published by ... estimated to reach $2.64 Billion by 2020, growing at ... to 2020). Browse 119 market T ...
(Date:7/1/2015)... YORK, Pa. , July 1, 2015  Unilife ... developer, manufacturer and supplier of injectable drug delivery systems, ... been amended as of June 30, 2015. This amendment ... least $20 million in cash receipts from customers during ... no other adjustments to any of the terms of ...
(Date:7/1/2015)... CAESAREA, Israel , July 1, 2015 /PRNewswire/ ... Diabetes Management Solution, today announced the appointment of Todd ... for the U.S.  Durniak brings to LabStyle over ... leadership, most recently as the Vice President and ... Insulet focused on delivering insulin supplies through durable ...
Breaking Medicine Technology:Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 2Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 3Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 4Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 2LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 3LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 4
... New to Antiretroviral Therapy Respond ... Similarly to Men and ... once-daily or twice-daily dosing of Abbott,s (NYSE:,ABT) protease inhibitor Kaletra(R) ... amount of HIV-1),and improving the immune system (increasing CD4 cells) ...
... a,biopharmaceutical company engaged in the discovery and development ... announced today,that Genentech, a collaborator, has moved a ... into a phase 1 clinical trial,that has begun ... and tolerability of both single and multiple doses ...
Cached Medicine Technology:Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 2Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 3Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 4Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 5Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 6Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 7Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 8Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3
(Date:7/1/2015)... ... 01, 2015 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... to their industry leading Scientific Advisory Board. LRF’s volunteer Scientific Advisory Board (SAB), ...
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. Surya Challa of Chesapeake Vein Center ... The Hampton Roads Show to discuss non-invasive CoolSculpting . On the show, Dr. ... , CoolSculpting fat reduction utilizes Cryolipolysis to literally freeze stubborn, unwanted fat away ...
(Date:7/1/2015)... ... July 01, 2015 , ... During the first week ... Sales Training and Development) and Chuck Corso (Associate Sales Trainer) participated in the ... LTEN brings together learning and development professionals from more than 300 life sciences ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Convoy of ... community celebration in the Twin Cities on Saturday, August 1, at Spring Lake Park ... community will provide more than $1 million worth of goods and services including free ...
(Date:7/1/2015)... ... 01, 2015 , ... Element Blue ™, a leading ... it has received trademark protection for its SensorInsight® computer software platform. SensorInsight® is ... multiple sources providing an environment where users can view and compare real-time and ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4
... a munificent $15 million to assist Lebanon to rise ... According to Foreign Minister Alexander// Downer, Australia has managed ... during the post-conflict time, to help rebuild a country ... will support restoring health infrastructure and providing adequate access ...
... "enormous silence" in India around adolescent sexual and reproductive ... of parents, in-laws, spouses// and elders, says a new ... (ICRW) and partners. ,More than half ... many adolescents, particularly unmarried girls, suffer serious reproductive health ...
... of more than three glasses of red wine a week ... cancer, according to research presented at// the 71st Annual Scientific ... Based on the results of this study, researchers suspect the ... a key role. Resveratrol is an anti-fungal chemical that occurs ...
... a supplement of cinnamon extract on a daily basis ... a condition associated// with increased risk of type-2 diabetes ... obesity, hypertension, and unstable glucose and insulin metabolism and ... current study was presented this month at the 47th ...
... third case of carrot juice-linked botulism has been reported in ... drank U.S.-produced carrot juice earlier// this month. ,According ... from Quebec while the first two are from Toronto. It ... ,The affected products are produced in California and sold ...
... studies have revealed that college students put on several pounds in ... college students gain an average of 15// pounds in their freshman ... to put on weight. ,The first study was conducted ... According to the study results, both girls and guys gained an ...
Cached Medicine News:Health News:Intervention Needed to Break 'Silence' on Reproductive Health 2Health News:Intervention Needed to Break 'Silence' on Reproductive Health 3Health News:Cinnamon extract in reduction of risk of metabolic syndrome 2
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
... Accu-Temp Cauteries provide a broad ... in a wide variety of ophthalmic ... packaged sterile, complete with a safety ... "off " position when not in ...
... The Luminary LASIK Light Probes provide ... that allows the corneal interface to be ... use of the Tindal effect and light ... of interface debris, epithelial deposits, flap edge ...
... EEG system designed to satisfy the needs ... center. Ready to use, Comet XL is ... and Photic Stimulator. Select from various mobile ... your individual needs. These powerful, easy-to-use EEG ...
Medicine Products: